Skip to content

Clinical trials

Phase 3 Dwarfism, Pituitary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism, Pituitary Phase: Phase 3 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20061
20091
20101
20141
20153
20161
20173
20191
20201
20212
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ascendis Pharma Endocrinology Division A/S4
AEterna Zentaris2
EMD Serono2
LG Life Sciences2
Novo Nordisk A/S2
Pfizer2
Teva Branded Pharmaceutical Products R&D, Inc.2
Ascendis Pharma A/S1
Changchun GeneScience Pharmaceutical Co., Ltd.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism, Pituitary23
Endocrine System Diseases5
Failure to Thrive4
Pituitary Diseases4
Brain Concussion1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.